Search Results - "HERTEL, Andreas"

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method by Rekowski, Jan, Hüttmann, Andreas, Schmitz, Christine, Müller, Stefan P, Kurch, Lars, Kotzerke, Jörg, Franzius, Christiane, Weckesser, Matthias, Bengel, Frank M, Freesmeyer, Martin, Hertel, Andreas, Krohn, Thomas, Holzinger, Jens, Brink, Ingo, Haberkorn, Uwe, Nyuyki, Fonyuy, van Assema, Daniëlle ME, Geworski, Lilli, Hasenclever, Dirk, Jöckel, Karl-Heinz, Dührsen, Ulrich

“…The value of interim 18F-FDG PET/CT (iPET)–guided treatment decisions in patients with diffuse large B-cell lymphoma (DLBCL) has been the subject of much…”
Get full text

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUV max Method by Rekowski, Jan, Hüttmann, Andreas, Schmitz, Christine, Müller, Stefan P, Kurch, Lars, Kotzerke, Jörg, Franzius, Christiane, Weckesser, Matthias, Bengel, Frank M, Freesmeyer, Martin, Hertel, Andreas, Krohn, Thomas, Holzinger, Jens, Brink, Ingo, Haberkorn, Uwe, Nyuyki, Fonyuy, van Assema, Daniëlle M E, Geworski, Lilli, Hasenclever, Dirk, Jöckel, Karl-Heinz, Dührsen, Ulrich

“…The value of interim F-FDG PET/CT (iPET)-guided treatment decisions in patients with diffuse large B-cell lymphoma (DLBCL) has been the subject of much debate…”
Get full text

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial by Hüttmann, Andreas, Rekowski, Jan, Müller, Stefan P., Hertenstein, Bernd, Franzius, Christiane, Mesters, Rolf, Weckesser, Matthias, Kroschinsky, Frank, Kotzerke, Jörg, Ganser, Arnold, Bengel, Frank M., La Rosée, Paul, Freesmeyer, Martin, Höffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Prange-Krex, Gabriele, Griesshammer, Martin, Holzinger, Jens, Wilop, Stefan, Krohn, Thomas, Raghavachar, Aruna, Maschmeyer, Georg, Brink, Ingo, Schroers, Roland, Gaska, Tobias, Bernhard, Helga, Giagounidis, Aristoteles, Schütte, Jochen, Dienst, Ariane, Hautzel, Hubertus, Naumann, Ralph, Klein, Alfred, Hahn, Dennis, Pöpperl, Gabriele, Grube, Matthias, Marienhagen, Jörg, Schwarzer, Andreas, Kurch, Lars, Höhler, Thomas, Steiniger, Heike, Nückel, Holger, Südhoff, Thomas, Römer, Wolfgang, Brinkmann, Marcus, Ose, Claudia, Alashkar, Ferras, Schmitz, Christine, Dürig, Jan, Hoelzer, Dieter, Jöckel, Karl-Heinz, Klapper, Wolfram, Dührsen, Ulrich

“…Standard first-line treatment of aggressive B cell lymphoma comprises six or eight cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)…”
Get full text

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial by Schmitz, Christine, Rekowski, Jan, Müller, Stefan P., Hertenstein, Bernd, Franzius, Christiane, Ganser, Arnold, Bengel, Frank M., Kroschinsky, Frank, Kotzerke, Jörg, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz‐Gert, Hertel, Andreas, Behringer, Dirk, Mesters, Rolf, Weckesser, Matthias, Mahlmann, Stefan, Haberkorn, Uwe, Martens, Uwe, Prange‐Krex, Gabriele, Brenner, Winfried, Giagounidis, Aristoteles, Moeller, Regina, Runde, Volker, Sandmann, Matthias, Hautzel, Hubertus, Wilop, Stefan, Krohn, Thomas, Dürk, Heinz, Heike, Michael, Alashkar, Ferras, Brinkmann, Marcus, Trenn, Guido, Wacker, Dietmar, Kreisel‐Büstgens, Christiane, Bernhard, Helga, Heil, Gerhard, Larisch, Rolf, Kurch, Lars, Jöckel, Karl‐Heinz, Hoelzer, Dieter, Klapper, Wolfram, Boellaard, Ronald, Dührsen, Ulrich, Hüttmann, Andreas

“…The prospective randomized Positron Emission Tomography (PET)‐Guided Therapy of Aggressive Non‐Hodgkin Lymphomas (PETAL) trial was designed to test the ability…”
Get full text

Follow-up in carriers of the 'MELAS' mutation without strokes by Damian, M S, Hertel, A, Seibel, P, Reichmann, H, Bachmann, G, Schachenmayr, W, Hoer, G, Dorndorf, W

“…Eight carriers of the A3243G mutation of mitochondrial DNA without stroke-like episodes were monitored for up to 7 years in clinical and metabolic studies, by…”
Get more information

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial by Hüttmann, Andreas, Müller, Stefan P, Rekowski, Jan, Hertenstein, Bernd, Franzius, Christiane, Franzke, Anke, Bengel, Frank M, Kroschinsky, Frank, Kotzerke, Jörg, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Mesters, Rolf, Weckesser, Matthias, Mahlmann, Stefan, Haberkorn, Uwe, Martens, Uwe, Prange-Krex, Gabriele, Korfel, Agnieszka, Brenner, Winfried, Giagounidis, Aristoteles, Moeller, Regina, Runde, Volker, Sandmann, Matthias, Hautzel, Hubertus, Wilop, Stefan, Krohn, Thomas, Dürk, Heinz, Strumberg, Dirk, Heike, Michael, Ose, Claudia, Brinkmann, Marcus, Trenn, Guido, Kloke, Otto, Kreisel-Büstgens, Christiane, Dang, Tu-Anh, Heil, Gerhard, Jöckel, Karl-Heinz, Hoelzer, Dieter, Klapper, Wolfram, Duehrsen, Ulrich

“…Introduction: The PETAL trial is a multicenter randomized controlled study for patients with aggressive lymphomas of diverse histologies (EudraCT…”
Get full text

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with B Cell Lymphomas Participating in the PETAL Trial by Duehrsen, Ulrich, Müller, Stefan P, Rekowski, Jan, Hertenstein, Bernd, Franzius, Christiane, Mesters, Rolf, Weckesser, Matthias, Kroschinsky, Frank, Kotzerke, Jörg, Franzke, Anke, Bengel, Frank M, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Prange-Krex, Gabriele, Griesshammer, Martin, Holzinger, Jens, Wilop, Stefan, Krohn, Thomas, Raghavachar, Aruna, Maschmeyer, Georg, Brink, Ingo, Schroers, Roland, Gaska, Tobias, Dang, Tu-Anh, Giagounidis, Aristoteles, Dienst, Ariane, Hautzel, Hubertus, Naumann, Ralph, Klein, Alfred, Hahn, Dennis, Pöpperl, Gabriele, Grube, Matthias, Marienhagen, Jörg, Schwarzer, Andreas, Kurch, Lars, Höhler, Thomas, Steiniger, Heike, Nückel, Holger, Südhoff, Thomas, Römer, Wolfgang, Brinkmann, Marcus, Ose, Claudia, Hoelzer, Dieter, Dürig, Jan, Jöckel, Karl-Heinz, Klapper, Wolfram, Hüttmann, Andreas

“…Introduction: The PETAL trial is a multicenter randomized controlled study for patients with aggressive lymphomas of diverse histologies (EudraCT…”
Get full text

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas – a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial) by Duehrsen, Ulrich, Hüttmann, Andreas, Müller, Stefan, Hertenstein, Bernd, Kotzerke, Jörg, Mesters, Rolf, Franzius, Christiane, Kroschinsky, Frank, Weckesser, Matthias, Franzke, Anke, Bengel, Frank, Dürig, Jan, Matschke, Johannes, Pöppel, Thorsten, Rekowski, Jan, Ose, Claudia, Brinkmann, Marcus, LaRosée, Paul, Freesmeyer, Martin, Hertel, Andreas, Hoeffkes, Heinz-Gert, Behringer, Dirk, Prange-Krex, Gabriele, Wilop, Stefan, Krohn, Thomas, Fricke, Eva, Griesshammer, Martin, Giagounidis, Aristoteles, Raghavachar, Aruna, Maschmeyer, Georg, Brink, Ingo, Brecht, Arne, Haberkorn, Uwe, Gaska, Tobias, Klapper, Wolfram, Hoelzer, Dieter, Jöckel, Karl-Heinz, Scherag, André, Bockisch, Andreas

“…Introduction: The predictive value of 18-fluorodeoxyglucose PET performed after a few cycles of chemotherapy has been questioned in aggressive lymphomas…”
Get full text

Quetiapine and Norquetiapine in Plasma and Cerebrospinal Fluid of Schizophrenic Patients Treated With Quetiapine: Correlations to Clinical Outcome and HVA, 5-HIAA, and MHPG in CSF by NIKISCH, Georg, BAUMANN, Pierre, WIEDEMANN, Georg, KIESSLING, Bernhard, WEISSER, Heike, HERTEL, Andreas, YOSHITAKE, Takashi, KEHR, Jan, MATHE, Aleksander A

“…This study investigated concentrations of quetiapine and norquetiapine in plasma and cerebrospinal fluid (CSF) in 22 schizophrenic patients after 4-week…”
Get full text

Relationship between dopamine D 2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine by Nikisch, Georg, Baumann, Pierre, Kießling, Bernhard, Reinert, Michael, Wiedemann, Georg, Kehr, Jan, Mathé, Aleksander A., Piel, Markus, Roesch, Frank, Weisser, Heike, Schneider, Peter, Hertel, Andreas

“…Combining measurements of the monoamine metabolites in the cerebrospinal fluid (CSF) and neuroimaging can increase efficiency of drug discovery for treatment…”
Get full text

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine by Nikisch, Georg, Baumann, Pierre, Kießling, Bernhard, Reinert, Michael, Wiedemann, Georg, Kehr, Jan, Mathé, Aleksander A, Piel, Markus, Roesch, Frank, Weisser, Heike, Schneider, Peter, Hertel, Andreas

“…Abstract Combining measurements of the monoamine metabolites in the cerebrospinal fluid (CSF) and neuroimaging can increase efficiency of drug discovery for…”
Get full text

Angiography and cerebral perfusion scintigraphy in balloon test occlusion of carotid artery in head and neck tumors by Hertel, A, Görling, S, Schwager, K, Hofmann, E

“…Surgery of head and neck tumors and other tumors involving the carotid artery may demand complete sacrifice of the carotid as part of the necessary tumor…”
Get more information

Retraction notice to “Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine” [J Psychiat Res 44 (2010) 754–759] by Nikisch, Georg, Baumann, Pierre, Kießling, Bernhard, Reinert, Michael, Wiedemann, Georg, Kehr, Jan, Mathé, Aleksander A, Piel, Markus, Roesch, Frank, Weisser, Heike, Schneider, Peter, Hertel, Andreas

“…This article has been retracted at the request of the Editors: please see Elsevier Policy on Article Withdrawal…”
Get full text

Relationship between dopamine D 2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine (Retraction of vol 44, pg 754, 2010) by Nikisch, G, Baumann, P, Kiessling, B, Reinert, M, Wiedemann, G, Kehr, J, Mathe, AA, Piel, M, Roesch, F, Weisser, H

Get full text

RETRACTED: Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine by Nikisch, Georg, Baumann, Pierre, Kießling, Bernhard, Reinert, Michael, Wiedemann, Georg, Kehr, Jan, Mathé, Aleksander A., Piel, Markus, Roesch, Frank, Weisser, Heike, Schneider, Peter, Hertel, Andreas

“…This article has been retracted: please see Elsevier Policy on Article Withdrawal (http: //www.elsevier.com/locate/withdrawalpolicy). This article has been…”
Get full text

Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD) by HENKEL, Karsten, ZERR, Inga, SPITZ, Jörg, POSER, Sigrid, HERTEL, Andreas, GRATZ, Klaus-F, SCHRÖTER, Andreas, TSCHAMPA, Henriette J, BIHL, Heiner, BÜLL, Udalrich, GRÜNWALD, Frank, DRZEZGA, Alexander

“…The aim of this study was to explore the sites of metabolic changes with [(18)F]2-fluoro-2-desoxy-D-glucose (FDG) and positron emission tomography (PET) in…”
Get full text

Intraoperative Gamma Probe Detection of Neuroendocrine Tumors by Adams, Stefan, Baum, Richard P, Hertel, Andreas, Wenisch, Hubertus J.C, Staib-Sebler, Elsbeth, Herrmann, Gunter, Encke, Albrecht, Hor, Gustav

“…Previous studies of the intraoperative use of a handheld gamma probe to localize metastases and primary tumors of colorectal cancer have shown improved…”
Get full text

Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings by Adams, S, Baum, R P, Hertel, A, Schumm-Draeger, P M, Usadel, K H, Hör, G

“…Early diagnosis of metastases of medullary thyroid carcinoma (MTC) provides the optimal condition for curative outcome. The aim of this study was to appraise…”
Get full text

Positron Emission Tomography (PET) for Staging and Evaluation of Response to Treatment in Patients with Hodgkin's Disease by Weidmann, Eckhart, Aican, Bianca B., Hertel, Andreas, Balm, Richard P., Chow, Kaiu, Knupp, Bernhard, Adams, Stefan, Hör, Gustav, Hoelzer, Dieter, Mitrou, Paris S.

“…Forty two examinations utilizing F-18 FDG-PET were performed in 23 patients with Hodgkin's disease to study for involved lymphoma regions and compared to…”
Get full text

PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients' diagnostic and therapeutic management by Mantaka, Panagiota, Baum, Richard P, Hertel, Andreas, Adams, Stefan, Niessen, Andreas, Sengupta, Sonali, Hör, Gustav

“…25 patients with cancer of unknown primary (CUP) were studied using PET-FDG. Whole-body-PET scans were performed based on previous morphological information…”
Get more information